Coindre J M, Trojani M, Contesso G, David M, Rouesse J, Bui N B, Bodaert A, De Mascarel I, De Mascarel A, Goussot J F
Cancer. 1986 Jul 15;58(2):306-9. doi: 10.1002/1097-0142(19860715)58:2<306::aid-cncr2820580216>3.0.co;2-7.
Tumor grade has been proposed as an essential factor in the staging of patients with soft tissue sarcomas. In a previous study, a histopathologic grading system using the evaluation of tumor differentiation, mitosis count, and tumor necrosis was described. The current study was conducted to test its reproducibility. The pathologic sections of 25 soft tissue sarcomas were submitted to a study group composed of 15 pathologists who had not been involved in the development of the grading system. The results were compared with those of a panel group. The crude proportion in agreement observed between the study group and the panel group was 81% for the evaluation of tumor necrosis, 74% for tumor differentiation, and 73% for the mitosis count. The crude proportion in agreement for the tumor grade was 75%, which was significantly better than the crude agreement rate of 61% for the diagnosis of histologic type (P = 0.001). A kappa statistical analysis, to check the possibility of chance-related concordance, showed a proportion in agreement of 68%. A two-way variance analysis showed that the homogeneity of the evaluation of tumor grade is impaired by tumor-related and observer-related factors. However, an improvement may be obtained by better training of pathologists. We conclude that the tumor grading system developed inside the French Federation of Cancer Centers, although perfectible, already provides reliable prognostic information and its use in prospective clinical studies may provide more information about its clinical usefulness.
肿瘤分级已被认为是软组织肉瘤患者分期的一个重要因素。在之前的一项研究中,描述了一种使用肿瘤分化评估、有丝分裂计数和肿瘤坏死情况的组织病理学分级系统。本研究旨在测试其可重复性。将25例软组织肉瘤的病理切片提交给一个由15名未参与该分级系统制定的病理学家组成的研究组。将结果与一个专家小组的结果进行比较。研究组与专家小组之间观察到的肿瘤坏死评估的总体一致比例为81%,肿瘤分化为74%,有丝分裂计数为73%。肿瘤分级的总体一致比例为75%,这显著优于组织学类型诊断的总体一致率61%(P = 0.001)。进行kappa统计分析以检查偶然相关一致性的可能性,结果显示一致比例为68%。双向方差分析表明,肿瘤分级评估的同质性受到肿瘤相关因素和观察者相关因素的损害。然而,通过对病理学家进行更好的培训可能会有所改善。我们得出结论,法国癌症中心联合会内部制定的肿瘤分级系统虽然仍有改进空间,但已经能够提供可靠的预后信息,并且在前瞻性临床研究中使用可能会提供更多关于其临床实用性的信息。